Ciprofloxacin Injection, Solution
Product Images NDC 25021-192

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 25021-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Cip0i 0000 01)

Chemical structure of ciprofloxacin, showing its bicyclic core with a piperazine ring, fluorine substitution, and carboxylic acid group as part of its molecular framework.*

FDA Label Image

Package Label – Principal Display Panel – Bag Label (Cip0i 0000 02)

Label for Ciprofloxacin Injection, USP 200 mg (2 mg/mL) in a 100 mL intravenous solution containing 5% dextrose. The label includes dosage concentration, directions for infusion over 60 minutes, and manufacturer information showing Sagent Pharmaceuticals as the labeler, with the product made in Switzerland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.